
Awards & Recognitions — 2025–2026. The Company's flagship brand "CareSens" has won the Korea First Brand Awards for 14 consecutive years and the Brand of the Year Awards for 13 consecutive years, demonstrating its status as a symbol of trust in the domestic Blood Glucose Monitoring (BGM) brand category.
Award | Category · Description | Timing | Significance |
2025 Korea First Brand Awards | Blood Glucose Meter Category (CareSens) | 2025 | 14 consecutive years of award (2012–2025) |
Korean Diabetes Association 30th Anniversary — Minister of Health and Welfare Award | Contribution to the development of the diabetes management industry | May 2025 (Korea Press Center) | Recognition of cumulative achievements over 30 years of cooperation with the Korean Diabetes Association and patient-centered value |
2025 Brand of the Year Awards | Blood Glucose Meter Category (CareSens) | 2025 | 13 consecutive years of award (2013–2025) |
CareSens Air 2 — Cross-Ministerial Whole-Cycle Medical Device R&D Final Evaluation "Excellent" | Government evaluation of CGM R&D | 2025 | Top tier in the 5-year comprehensive national R&D evaluation; foundation for 2027 global launch |
CGM "CareSens Air" upgrade — Korea and Europe Launch | Full-scale entry into the EU CGM market | 2025 | Global leap based on LifeScan partnership + EU CE certification |
Wonju Plant — Selected as an "Excellent Worksite for Worker Health Promotion Activities" | Hosted by the Korea Occupational Safety and Health Agency | January 2026 | Recognition of excellence in employee safety and health management |
On May 23, 2025, at the PLAZA Club Hall of the Korea Press Center, the Korean Diabetes Association 30th Anniversary Ceremony and Symposium was held, at which i-SENS, Inc. received the Minister of Health and Welfare Award. This recognition reflects cumulative achievements over 30 years of cooperation and patient-centered value.
Item | GRI | ESRS | Significance |
Awards from external associations and government evaluations | 2-28 (Membership) | G1 (Business Conduct) | Strengthened credibility through recognition by external stakeholders |
Medical device R&D government evaluation (CGM) | 3-3 (Topic Management) | ESRS 2 IRO-1 | National R&D comprehensive evaluation of "Excellent" — patient safety and innovation achieved simultaneously |
Excellent Worksite for Worker Health Promotion | 403-3 (Occupational Health) | S1-14 | Recognition by the Korea Occupational Safety and Health Agency — external verification of safety and health |
Award for 30-year cooperation with the Diabetes Association | 413-1 (Local Community) | S3 (Affected Communities) | Recognition of long-term cooperation with patients and patient organizations |